A

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

Senior Medical Safety Scientist

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A PharmD, PhD, MS, MSN, MPH, RN, NP, PA, or equivalent degree from an accredited institution is required.
  • At least 7 years of experience in drug safety, pharmacovigilance, clinical safety, or risk management within the pharmaceutical or biotechnology industry is required.
  • Experience in safety surveillance, signal detection and management, aggregate safety data review, benefit-risk assessment, and product safety evaluation is required.
  • Experience authoring regulatory safety documents, including signal assessments, DSURs, PBRERs, safety sections of clinical documents, aggregate reports, and health authority responses is required.
  • Advanced knowledge of FDA, EU, and ICH regulations and guidelines related to pharmacovigilance, clinical trial safety monitoring, signal management, aggregate reporting, and post-marketing surveillance is required.
  • Expertise in safety signal detection, validation, evaluation, and risk assessment methodologies is required.
  • Experience with pharmacovigilance databases and safety systems, including Argus Safety, as well as signal detection tools is required.
  • Strong knowledge of MedDRA coding conventions, safety data review methodologies, and adverse event analysis is required.
  • Proficiency in Microsoft Office Suite, including Word, Excel, and PowerPoint, is required.
  • Ability to travel domestically and internationally as required.

Responsibilities

  • Serve as the scientific safety lead for assigned products, providing pharmacovigilance expertise across clinical development and post-marketing activities.
  • Conduct routine and ad hoc review of safety data from clinical trials, post-marketing sources, literature, business partners, and other relevant sources to support ongoing safety surveillance.
  • Lead signal detection, validation, evaluation, tracking, and aggregate safety analyses, including review of case series, adverse event trends, data mining outputs, and benefit-risk assessments.
  • Author and maintain key safety deliverables, including signal assessments, safety evaluations, benefit-risk assessments, safety narratives, AOSEs, Safety Surveillance Plans (SSPs), and signal management documentation.
  • Support aggregate safety reports, regulatory submissions, health authority responses, core safety information, Risk Management Plans (RMPs), REMS activities, and other product risk management initiatives.
  • Provide scientific safety expertise to governance committees and cross-functional teams, including Clinical Development, Regulatory Affairs, Biostatistics, Medical Writing, Epidemiology, Medical Affairs, and Quality.
  • Review safety listings, line listings, adverse event summaries, and retrospective safety data analyses to identify and evaluate emerging safety concerns and risks.
  • Support audits, inspections, and regulatory authority inspections by ensuring safety documentation is accurate, complete, and inspection ready while maintaining compliance with global pharmacovigilance regulations and Good Pharmacovigilance Practices (GVP).
  • Maintain current knowledge of safety science methodologies, signal management practices, and evolving global regulatory requirements.
  • Perform other duties as assigned.

About the Company

Acadia Pharmaceuticals

Develops and commercializes CNS disorder therapies

ACADIA Pharmaceuticals develops and commercializes medicines for central nervous system (CNS) disorders, focusing on neurological and psychiatric conditions with unmet medical needs. Its work centers on identifying drug candidates, advancing them through preclinical and clinical trials, and, upon regulatory approval, bringing therapies to market. Its products address CNS conditions such as Parkinson's disease psychosis, reflecting a commitment to treating complex brain disorders. The company combines in-house research with potential strategic collaborations to expand its portfolio and reach. Unlike peers that rely on a single development path, ACADIA emphasizes a broad pipeline and the ability to commercialize approved therapies, aiming to provide effective CNS treatments to patients and improve outcomes in mental health and neuroscience.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1993

Recently Posted Jobs

Explore more opportunities at Acadia Pharmaceuticals

See more jobs